-+ 0.00%
-+ 0.00%
-+ 0.00%

Cormedix Sees Q1 Sales $300.000M-$320.000M vs $108.873M Est

Benzinga·03/05/2026 12:51:08
Listen to the news
Cormedix (NASDAQ:CRMD) sees Q1 sales of $300.000 million-$320.000 million vs $108.873 million analyst estimate.